PFIZER INC (PFE)
Clinical trial NCT06989437: enrollment: not set → 982 participants.
NATERA, INC. (NTRA)
Clinical trial NCT05837663: enrollment: not set → 600 participants.
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT07458243: enrollment: not set → 60 participants.
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT05486793: enrollment: not set → 240 participants.
ASTRAZENECA PLC (AZN)
Clinical trial NCT05918042 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-07-31 → 2025-05-29 3. primary completion date: 2025-07-31 → 2025-05-29 4. enrollment: not set → 414 participants
SHANGHAI PHARMACEUTICALS HOLDINGS CO., LTD. (SHPMY)
Clinical trial NCT07374848 updates: 1. start date: 2026-03-01 → 2026-03-02 2. enrollment: not set → 180 participants
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT06976216: enrollment: not set → 586 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT03924856 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-09-01 → 2026-05-18 3. enrollment: not set → 907 participants
INTEGRATIVE HEALTH TECHNOLOGIES, INC. (IHTI)
Clinical trial NCT06091202 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 608 participants
NOVARTIS AG (NVSEF)
Clinical trial NCT00159484 updates: 1. status: UNKNOWN → COMPLETED 2. start date: 2004-10-01 → 2004-10-12 3. completion date: 2017-12-01 → 2023-03-23 4. primary completion date: 2016-12-01 → 2015-01-13 5. enrollment: not set → 75 participants